Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources
  5. Charts

Charts

  • Diabetes (713)
  • Endocrinology (8)
  • Hyperglycemia (32)
  • Hypoglycemia (16)
  • Other (31)
  • Prediabetes (5)
  • Resources (272)
    • Charts (55)
    • Guidelines (81)
    • Letters (3)
    • Natural Medicines / Supplements (4)
    • Patient Education (12)
    • PL Voices (153)
    • Quality Measures (39)
  • Thyroid Disorders (53)
46 - 55 of 55 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Commentary: Selecting a Sulfonylurea April 2009
Commentary: How Much Insulin Is Too Much? January 2009
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Exubera Off the Market November 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction July 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction June 2007
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved